Chen Ling-Xiao, Li Yu-Lin, Ning Guang-Zhi, Li Yan, Wu Qiu-Li, Guo Jin-Xiu, Shi Hong-Yu, Wang Xiao-Bo, Zhou Yong, Feng Shi-Qing
Department of Orthopaedics, Tianjin Medical University General Hospital, 154 Anshan Road, Heping District, People's Republic of China.
PLoS One. 2015 Apr 13;10(4):e0123153. doi: 10.1371/journal.pone.0123153. eCollection 2015.
The question which kind of methods is most suitable for treating the old people for osteoporotic vertebral compression fracture is still discussed and pairwise meta-analyses cannot get hierarchies of these treatments. Our aim is to integrate the evidence to provide hierarchies of the comparative efficacy measured by the change of VAS (Visual Analogue Scale) and tolerability measured by incidence of new fractures and risk of all-cause discontinuation on three treatments (percutaneous vertebroplasty (PVP)、balloon kyphoplasty (BK) and conservative treatment (CT)).
We performed a Bayesian-framework network meta-analysis of randomized controlled trials (RCTs) to compare three treatments for the old people with osteoporotic vertebral compression fracture. The eligible RCTs were identified by searching Amed, British Nursing Index, Embase, Pubmed, the Cochrane Central Register of Controlled Trials (CENTRAL), Google scholar, SIGLE, the National Technical Information Service, the National Research Register (UK) and the Current Controlled Trials databases. Data from three outcomes (e.g. VAS, risk of all-cause discontinuation and incidence of new fractures) were independently extracted by two authors.
A total of five RCTs were finally included into this article. PVP and BK significantly decreased VAS when compared with CT. BK had a significantly lower risk of all-cause discontinuation contrast to CT. Three treatments (BK, PVP and CT) had no significant differences in the incidence of new fractures.
PVP may be the best way to relieve pain, CT might lead to the lowest incidence of new fractures and BK might had the lowest risk of all-cause discontinuation in old people with osteoporotic vertebral compression fracture. More large-scale and longer duration of follow-up studies are needed.
哪种方法最适合治疗老年人骨质疏松性椎体压缩骨折的问题仍在讨论中,成对荟萃分析无法得出这些治疗方法的等级关系。我们的目的是整合证据,以提供通过视觉模拟量表(VAS)变化衡量的比较疗效等级,以及通过三种治疗方法(经皮椎体成形术(PVP)、球囊扩张椎体后凸成形术(BK)和保守治疗(CT))的新骨折发生率和全因停药风险衡量的耐受性等级。
我们对随机对照试验(RCT)进行了贝叶斯框架网络荟萃分析,以比较三种治疗老年人骨质疏松性椎体压缩骨折的方法。通过检索Amed、英国护理索引、Embase、Pubmed、Cochrane对照试验中央注册库(CENTRAL)、谷歌学术、SIGLE、美国国家技术信息服务局、国家研究注册库(英国)和当前对照试验数据库来识别符合条件的RCT。来自三个结局(如VAS、全因停药风险和新骨折发生率)的数据由两位作者独立提取。
本文最终共纳入五项RCT。与CT相比,PVP和BK显著降低了VAS。与CT相比,BK的全因停药风险显著更低。三种治疗方法(BK、PVP和CT)在新骨折发生率方面无显著差异。
在患有骨质疏松性椎体压缩骨折的老年人中,PVP可能是缓解疼痛的最佳方法,CT可能导致新骨折发生率最低,BK可能全因停药风险最低。需要更多大规模、更长随访期的研究。